INOVIO COVID-19 vaccine trials on partial hold after additional queries from US FDA
Working to address the FDA's questions and plans to respond in October, informed the company
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
IONTAS and FairJourney Biologics find COVID-19 neutralizing antibodies with picomolar potency
This viral neutralization efficiency was independently verified by the National Institute for Biological Standards and Control
IIT Delhi researchers find Teicoplanin effective in treating COVID -19 virus
Teicoplanin is an FDA-approved glycopeptide antibiotic used to treat gram-positive bacterial infections with low toxicity profile…
CSIR announces Shanti Swarup Bhatnagar Prize 2020 to 14 scientists
The scientists work in renowned national research and academic institutions across the country
J&J COVID-19 vaccine candidate yields strong immune response in early trial
Immune response results were available from only 15 people over 65 years old, limiting the interpretation
Scientists identify highly effective coronavirus antibodies which may lead to passive COVID-19…
The so-called neutralising antibodies bind to the virus, as crystallographic analysis reveals, and thus prevent the pathogen from…
Bacterial viperins prove effective against human viruses: Researchers
The molecules produced by the bacterial viperins are currently undergoing testing against human viruses such as the influenza…
Novavax begins late-stage trial of COVID-19 vaccine in the UK
Data from the trial - likely over the next four to six weeks - will support regulatory submissions for license in the UK, EU and…
Panacea Biotec completes Phase I/II study of DengiAll, a tetravalent dengue vaccine candidate
The company has approached DGCI to seek accelerated review of its data to bring DengiAIl to market quickly
CSIR and Mylan in partnership to develop therapeutic options for COVID–19 management
The application for the clinical trials has been submitted to DCGI for regulatory approval
Scientists find new drug that may be able to prevent or mitigate severe COVID-19 infection
Repurposing the 4-PBA anti-stress drug could modulate such cellular stress and curb mortality caused by respiratory failure…
Phase III trials of Covishield vaccine in Pune next week
Around 150 to 200 volunteers will be administered the vaccine candidate dose
Trodelvy from Immunomedics extends survival in breast cancer patients
The FDA granted the drug accelerated approval for its use in metastatic triple-negative breast cancer (mTNBC) patients who had…
Experimental drug blocks COVID-19 viral entry into lung cells
Researchers at NYU Grossman School of Medicine made changes to a free ACE2 molecule and then fused one part of it to a piece of an…
GoI publishes research procedure for COVID-19 vaccine candidates
Over 30 vaccine candidates are in different stages of development in the country
Moderna would seek EUA in US for COVID-19 vaccine based on early data
If the interim readout is deemed by the independent safety committee as positive with 70 or 80 or 90 per cent efficacy, we will…
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by…
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:…
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
UK researchers to test inhaled versions of Oxford and Imperial COVID-19 vaccine candidates
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a…
SpringWorks Therapeutics in pact with Janssen to assess Nirogacestat with Teclistamab in patients…
Third collaboration to evaluate nirogacestat in combination with BCMA therapies across modalities